Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: YZYC2 sedaDNA 2022

PROVIDER: PRJNA976243 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR24767215_1.fastq.gz	Fastqsanger.gz
	SRR24767215_2.fastq.gz	Fastqsanger.gz
	SRR24767216_1.fastq.gz	Fastqsanger.gz
	SRR24767216_2.fastq.gz	Fastqsanger.gz
	SRR24767217_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 126

Similar Datasets

Project description:HOOPLA sedaDNA

| PRJNA1104619 | ENA

sedaDNA Lake Lama

Project description:sedaDNA Lake Lama

| PRJEB80877 | ENA

sediment metagenome

Project description:Beppu Bay sedaDNA

| PRJDB12862 | ENA

Project description:Santa Barbara Basin sedaDNA

| PRJNA766251 | ENA

Project description:Marine eukaryote sedaDNA extractions

| PRJNA558683 | ENA

Genomic and transcriptomic determinants of clinical outcomes in patients with AML and DNMT3A mutations

Project description:Acute myeloid leukemia (AML) and DNMT3A mutations (DNMT3Amut) are considered to carry intermediate risk under the 2022 European LeukemiaNet (ELN-2022) classification in the absence of other co-mutations or cytogenetic abnormalities. However, this group is highly heterogeneous. In this study, the genomic and transcriptomic features influencing outcomes in DNMT3A-mutated AML were examined in a cohort of 884 patients with AML receiving standard chemotherapy. Stratification by NPM1 and FLT3-ITD status revealed worse survival among patients with NPM1 mutations and wild-type FLT3-ITD (NPM1mut/FLT3-ITDwt) than patients in the ELN-2022 favorable risk group. The other three subgroups (NPM1mut/FLT3-ITDmut, NPM1wt/FLT3-ITDmut, and NPM1wt/FLT3-ITDwt) exhibited worse prognoses than patients in the ELN-2022 intermediate risk group. Additionally, the presence of TET2mut in patients with AML and DNMT3Amut/NPM1mut/FLT3-ITDwt led to reclassification from favorable risk to intermediate risk in the ELN-2022. RNA-sequencing analysis revealed a distinct transcriptomic profile in patients with TET2mut, highlighting the enrichment of leukemic stem cell signatures and dendritic cell migration, with MMP14, CD200, and CT45A5 identified as key differentially expressed genes. In conclusion, co-mutation patterns strongly affected AML outcomes in patients with DNMT3Amut. Patients with TET2mut constituted a unique subgroup within the ELN-2022 favorable DNMT3Amut/NPM1mut/FLT3-ITDwt group, characterized by distinct transcriptomic features and an unfavorable prognosis.

2025-05-19 | GSE297413 | GEO

MicroRNA expression profiling in the adult offspring of rats with periodontal disease

Project description:The present study investigated whether maternal periodontal disease modifies the microRNA expression profile in adult offspring. *************************************************************** This study was supported by the São Paulo Research Foundation (FAPESP) [grant #2019/04183-9; #2022/08872-6; #2023/03786-7; #2023/12488-0; #2023/01400-4] and CNPq [grant 151151/2023-7], São Paulo, SP, Brazil. The grants #2019/04183-9; #2023/12488-0; #2023/01400-4 and 151151/2023-7 were awarded to the author Maria Sara de Lima Coutinho Mattera. The grant #2022/08872-6 was awarded to Heloisa Macedo Sampaio. The grant #2023/03786-7 was awarded to Gabriele Fernandes Baliero. ***************************************************************

2024-12-28 | GSE281235 | GEO

Project description:IODP Exp. 382 sedaDNA deep

| PRJNA861836 | ENA

Iceland Marine Biodiversity

Project description:Northern Iceland sedaDNA Marine Biodiversity

| PRJEB78865 | ENA

Project description:sedaDNA analysis of Durrington Walls

| PRJNA1101222 | ENA